Cannae is a holding company engaged in managing and operating a group of companies and investments. The company's segments are: Restaurant Group, which consists of the operations of American Blue Ribbon Holdings, LLC and 99 Restaurants Holdings, LLC; Ceridian, which consists of the operations of the company's subsidiary, Ceridian HCM Holding, Inc., a global human capital management software company; T-System, which consists of the operations of the company's subsidiary, T-System Holdings, LLC, a provider of clinical documentation and coding solutions; and Corporate and Other, which consists of the company's share in the operations of controlled and uncontrolled portfolio companies.

Dollar Tree is an operator of discount variety stores. The company's stores operate under the names of Dollar Tree, Family Dollar and Dollar Tree Canada. The company's segments are: Dollar Tree, which is the operator of discount variety stores providing merchandise at the fixed price point of $1.00; and Family Dollar, which operates general merchandise discount retail stores. The merchandise mix in the company's Dollar Tree stores consists of consumable merchandise, variety merchandise, and seasonal goods. The merchandise mix in the company's Family Dollar stores consists of consumable merchandise, home products, apparel and accessories merchandise, and seasonal and electronics merchandise.

Evofem Biosciences is a clinical-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company is utilizing its proprietary Multi-purpose Vaginal pH Regulator ? (MVP-R) platform to develop its product candidate, Amphora (L-lactic acid, citric acid, and potassium bitartrate), which is used for potential indications such as prevention of pregnancy, prevention of urogenital Chlamydia trachomatis infection in women and prevention of urogenital Neisseria gonorrhoeae infection in women. The company is also developing its MVP-R gel product candidate for the treatment of recurrent bacterial vaginosis.

Franchise Group is a holding company. Through its subsidiaries, the company is engaged as a franchisor and operator of a system of income tax preparation offices located in the United States and Canada. The company also facilitates refund-based tax settlement financial products, such as Refund Transfer products and personal income tax refund discounting. The company also provides online tax preparation services. The company's tax settlement products: refund transfer products, which involves direct deposit of the customer's tax refund into a newly established temporary bank account in the customer's name and refund-based loans, which provides digital online tax services.

National Bankshares is a financial holding company. Through its bank subsidiary, the National Bank of Blacksburg, the company provides a range of retail and commercial banking services to individuals, businesses, non-profits and local governments from its branch offices throughout southwest Virginia and a loan production office in Roanoke, VA. Loan types include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity and various consumer loan products. The company's subsidiary, National Bankshares Financial Services, Inc., provides non-deposit investment products and insurance products for sale to the public.

Nicholas Financial is a holding company. Through its subsidiary, Nicholas Financial, Inc., the company is engaged primarily in acquiring and servicing automobile finance installment contracts (Contracts) for purchases of used and new automobiles and light trucks. In addition, the company also originates direct consumer loans (Direct Loans) and sells consumer-finance related products. For Automobile Finance Business - Contracts, the company is engaged in the business of providing financing programs, on behalf of purchasers of used cars and light trucks. For Contract Procurement, the Contracts purchased by the company is for used vehicles. For Direct Loans, the loans originated directly between the company and the consumer.

ProPhase Labs is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products, dietary supplements and other remedies, including the development and marketing of dietary supplements under the TK Supplements? brand. The company's subsidiary, Pharmaloz Manufacturing Inc., is a manufacturer and distributor of non-GMO, organic and/or natural-based cough drops and lozenges and OTC drug and dietary supplement products. The company's TK Supplements? product line includes Legendz XL?, a male sexual enhancement, Triple Edge XL?, an energy and stamina booster, and Super Prostaflow+?, a supplement to support prostate and urinary health.

Safehold is a holding company. Through its subsidiaries, the company operates its business through one segment by acquiring, managing and capitalizing ground leases. Ground leases generally represent the ownership of land underlying commercial real estate properties, which are leased on a long-term basis (base terms are 30 to 99 years, often with tenant renewal options) by the land owner to a tenant that owns and operates the building on top of the land, or what the company refer to as a Safehold?.

Sumo Group is engaged in the development of video games providing both turnkey and co-development solutions. Co.'s development solution, includes initial concept and pre-production, production and development, and post-release support. Co. develops games across all console platforms, PC, handheld and mobile devices.

Viking Therapeutics is a biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company's main clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta in development for patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's second clinical program's primary drug candidate, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in development for patients recovering from non-elective hip fracture surgery. The company is also developing VK0214 for X-linked adrenoleukodystrophy.